Advertisements


Dow Jones Newswires: AstraZeneca profit misses forecasts and warns outlook hinges on COVID-19

The FTSE 100-listed drug maker reported that core operating profit slid 29% to $1.55 billion......»»

Category: topSource: marketwatchFeb 14th, 2020

Chipotle"s profit misses estimates as COVID-19 costs mount

Excluding one-time items, the company earned $3.48 per share, missing the estimate of $3.73, according to IBES data from Refinitiv.....»»

Category: topSource: foxnewsFeb 3rd, 2021

Otis stock set for gains after profit and revenue rose above forecasts, and upbeat outlook

Shares of Otis Wor.....»»

Category: topSource: marketwatchFeb 1st, 2021

Eli Lilly beats profit and sales forecasts, to deliver 500,000 more COVID-19 treatment doses by end of March

Eli Lilly & Co. reported Friday a big fourth-quarter profit beat and revenue that rose 22% to top forecasts, as it recognized $850 million in U.S. revenue for bamlanivimab, the drugmaker's treatment for mile to moderate COVID-19 that has been grant.....»»

Category: topSource: marketwatchJan 29th, 2021

J&J Covid-19 vaccine data due "soon" as drug maker boosts outlook

The world’s biggest maker of health care products topped profit and sales expectations......»»

Category: topSource: foxnewsJan 26th, 2021

Lockheed Martin misses profit views but beats on sales, stock falls

Shares of Lockheed Martin Corp. slipped 1.1% in premarket trading Tuesday, after the aerospace and defense company reported fourth-quarter profit that rose less than expected while sales topped forecasts, and provided an in-line ful.....»»

Category: topSource: marketwatchJan 26th, 2021

Xerox stock slips after profit misses expectations, but revenue tops forecasts

Shares of Xerox Holdings Corp. slipped 0.6% in premarket trading Tuesday, after the copier and printer maker reported a fourth-quarter profit that missed expectations.....»»

Category: topSource: marketwatchJan 26th, 2021

Toyota expects profit to drop 80% this year as coronavirus saps car sales

Toyota's outlook came as global rivals have refrained from issuing forecasts.....»»

Category: topSource: foxnewsMay 12th, 2020

Thomson Reuters cuts sales outlook, narrowly misses earnings

Thomson Reuters reported higher quarterly sales and operating profit that fell slightly short of Wall Street estimates on Tuesday, while cutting its full-year sales outlook due to disruption to the global economy from the coronavirus crisis......»»

Category: topSource: reutersMay 5th, 2020

Thomson Reuters narrowly misses earnings, cuts sales outlook

Thomson Reuters Corp reported higher quarterly sales and operating profit that fell slightly short of Wall Street estimates on Tuesday and cut is full-year sales outlook, citing unprecedented disruption in the global economy......»»

Category: topSource: reutersMay 5th, 2020

Honeywell tops profit expectations but misses on sales, suspends guidance

Honeywell International Inc. reported Friday a first-quarter profit that rose above expectations, but sales that fell more than forecast as the industrial conglomerate said the COVID-19 pandemic had a significant impact on its supply chain, customer si.....»»

Category: topSource: marketwatchMay 1st, 2020

Humana beats profit and revenue forecasts, raises Medicare Advantage membership growth outlook

Humana Inc. reported Wednesday first-quarter profit and revenue that beat expectations, and affirmed its full-year earnings outlook while raising its Medicare Advantage (MA) membership guidance. The health Care company said net incom.....»»

Category: topSource: marketwatchApr 29th, 2020

AstraZeneca sticks to 2020 outlook, boosted by drug stockpiling

AstraZeneca topped analysts' estimates for quarterly profit and reiterated its targets for the year on Wednesday, as the British drugmaker benefited from higher demand for some of its medicines during the coronavirus pandemic......»»

Category: topSource: reutersApr 29th, 2020

AstraZeneca beats first-quarter profit estimates, retains 2020 forecast

AstraZeneca on Wednesday beat analysts' estimates for first-quarter profit and reiterated its outlook for 2020, as demand for the company's newer medicines remained steady......»»

Category: topSource: reutersApr 29th, 2020

Dow Jones Newswires: Nestle backs 2020 guidances, but reports drop in sales

Nestle SA said Friday that sales fell in the first quarter and backed its full-year guidance as it is still early to assess the full impact of Covid-19......»»

Category: topSource: marketwatchApr 24th, 2020

CSX pulls financial forecasts as profit and U.S. railroad volumes fall

U.S. railroad operator CSX Corp on Wednesday withdrew its financial forecasts and said it was evaluating future spending as business shutdowns triggered by the COVID-19 pandemic weigh on the U.S. economy......»»

Category: topSource: reutersApr 22nd, 2020

CSX profit falls as coal, automotive declines weigh on results

U.S. railroad operator CSX Corp on Wednesday withdrew its financial forecasts and said it was evaluating future spending as business shutdowns because of the COVID-19 pandemic weigh on the U.S. economy......»»

Category: topSource: reutersApr 22nd, 2020

Rogers pulls 2020 outlook, misses estimates as coronavirus crisis deepens

Canada's Rogers Communications Inc on Wednesday pulled its 2020 forecast and reported lower-than-expected quarterly profit due to a drop in ad sales and weaker demand for its wireless services as a result of the coronavirus outbreak......»»

Category: topSource: reutersApr 22nd, 2020

Elevator maker Kone"s first-quarter profit beats forecasts

Finland's Kone reported a 10% fall in first-quarter profit hurt by the coronavirus outbreak but beat forecasts and stuck with its recently adjusted 2020 outlook......»»

Category: topSource: reutersApr 22nd, 2020

Dow Jones Newswires: Roche backs 2020 view as first-quarter sales rise

Roche Holding AG said Wednesday that sales rose in the first quarter and backed its full-year outlook......»»

Category: topSource: marketwatchApr 22nd, 2020

Dow Jones Newswires: Roche developing coronavirus serology test

The Swiss drug maker said the Elecsys Anti-Sars-CoV-2 immunoassay is an in-vitro test to detect antibodies and assess the body’s immune reaction to Sars-CoV-2, better known as Covid-19, using human serum and plasma from a blood sample......»»

Category: topSource: marketwatchApr 17th, 2020